Stay updated on Nivolumab Ipilimumab RT for Sarcoma Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Ipilimumab RT for Sarcoma Clinical Trial page.

Latest updates to the Nivolumab Ipilimumab RT for Sarcoma Clinical Trial page
- Check3 days agoChange DetectedThe Study Details page shows a refreshed layout and updated labels, with core study information and eligibility criteria remaining unchanged; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check10 days agoNo Change Detected
- Check31 days agoChange DetectedThe page now shows newer operating status information, updated timing and version details (v3.2.0) with new dates, while old dates and the previous revision (v3.1.0) are removed.SummaryDifference3%

- Check39 days agoChange DetectedMajor update toward immunology and biomedical content (new topics like antigens, receptors, immune checkpoints) with removal of unrelated physics topics; page revision updated to v3.1.0.SummaryDifference1%

- Check53 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2; the 'Back to Top' element was removed.SummaryDifference0.1%

- Check60 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.1%

- Check68 days agoChange DetectedThe web page has been updated to include a new facility name and location, along with additional publications related to undifferentiated pleomorphic sarcoma. However, several previous resources and topics related to soft tissue sarcoma and urogenital diseases have been removed.SummaryDifference7%

Stay in the know with updates to Nivolumab Ipilimumab RT for Sarcoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Ipilimumab RT for Sarcoma Clinical Trial page.